In this report, Argaam highlights the expected results of Middle East Pharmaceutical Industries Co. (Avalon Pharma) for Q3 2025, its key events, and quarterly profit and sales, as well as performance and profitability indicators.
&nbs
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: